Rewatch the full session below or on Zoom. The full presentation from Day 3 is here.
E-labelling as a pathway to a future Universal Label
Session objectives:
Share the experience of adopting e-labelling, and opportunities for further harmonization and better interoperability.
Open a dialogue on the concept of universal labelling, in the context of an evolving digital healthcare ecosystem highlighting its potential to streamline supply chain logistics, reduce packaging waste, and support a green economy.
Examine how these systems may alleviate drug shortages, enhance preparedness for future pandemics, and expedite manufacturing processes.
By initiating this vital conversation now, the session seeks to align direction around future digital labelling options.
Combining strengths: Preparing regulatory systems for combination products for advanced therapies and biologics
Session objectives:
Raise awareness on the current global regulatory landscape on ATMPs and Drug-Devices combination products (DDCPs).
Share regulatory best practices and challenges in the APEC region.
Discuss the need for capacity-building activities on ATMPs and DDCPs.
Discuss the opportunity to develop for the APEC region a cooperative network of experts and an effective roadmap for a combined approach for ATMPs and DDCPs.
